Nakayama T - Search Results

1

Patient Preference for Surgical Methods for Ipsilateral Breast Tumor Recurrence.

Seto Y, Ishitobi M, Shien T, Oshiro C, Inoue H, Shima H, Kuba S, Watanabe N, Iwatani T, Nakayama T. Seto Y, et al. Among authors: nakayama t. Ann Surg Oncol. 2024 Jul;31(7):4512-4517. doi: 10.1245/s10434-024-15282-0. Epub 2024 Apr 9. Ann Surg Oncol. 2024. PMID: 38594578

2

Regional lymphatic recurrence after salvage surgery for ipsilateral breast tumor recurrence of breast cancer without local treatment for regional lymphatic basin.

Ishitobi M, Matsushita A, Nakayama T, Motomura K, Koyama H, Tamaki Y. Ishitobi M, et al. Among authors: nakayama t. J Surg Oncol. 2014 Sep;110(3):265-9. doi: 10.1002/jso.23642. Epub 2014 May 26. J Surg Oncol. 2014. PMID: 24863697

3

Treatment sequence of aromatase inhibitors and radiotherapy and long-term outcomes of breast cancer patients.

Ishitobi M, Shiba M, Nakayama T, Motomura K, Koyama H, Nishiyama K, Tamaki Y. Ishitobi M, et al. Among authors: nakayama t. Anticancer Res. 2014 Aug;34(8):4311-4. Anticancer Res. 2014. PMID: 25075064

4

Association of human epidermal growth factor receptor 2 status with ipsilateral breast tumor recurrence and resistance to endocrine therapy.

Ishitobi M, Shiba M, Nakayama T, Koyama H, Tamaki Y. Ishitobi M, et al. Among authors: nakayama t. Mol Clin Oncol. 2015 Jul;3(4):843-846. doi: 10.3892/mco.2015.534. Epub 2015 Mar 30. Mol Clin Oncol. 2015. PMID: 26171193 Free PMC article.

5

Distant Recurrence Risk after Late Ipsilateral Breast Tumor Recurrence: Results of a Retrospective, Single-Institution Study.

Ishitobi M, Okuno J, Kittaka N, Nakayama T, Koyama H, Tamaki Y. Ishitobi M, et al. Among authors: nakayama t. Oncology. 2015;89(5):269-74. doi: 10.1159/000437440. Epub 2015 Aug 15. Oncology. 2015. PMID: 26484529

6

Efficacy and safety of re-induction therapy with bevacizumab and paclitaxel for metastatic breast cancer.

Yoshinami T, Yagi T, Okuno J, Kittaka N, Ishitobi M, Sugimoto N, Nakayama T, Tamaki Y, Imamura F. Yoshinami T, et al. Among authors: nakayama t. Breast Cancer. 2017 Jan;24(1):147-151. doi: 10.1007/s12282-016-0686-3. Epub 2016 Mar 24. Breast Cancer. 2017. PMID: 27010394 Clinical Trial.

7

Distant recurrence risk following early ipsilateral breast tumor recurrence.

Ishitobi M, Okuno J, Kittaka N, Nakayama T, Koyama H, Tamaki Y. Ishitobi M, et al. Among authors: nakayama t. Oncol Lett. 2017 May;13(5):2886-2890. doi: 10.3892/ol.2017.5797. Epub 2017 Mar 3. Oncol Lett. 2017. PMID: 28521393 Free PMC article.

8

Safety for Repeat Lumpectomy Without Radiotherapy for Ipsilateral Breast Tumor Recurrence.

Ishitobi M, Fukui R, Hashimoto Y, Kittaka N, Nakayama T, Tamaki Y. Ishitobi M, et al. Among authors: nakayama t. Anticancer Res. 2017 Sep;37(9):5293-5299. doi: 10.21873/anticanres.11955. Anticancer Res. 2017. PMID: 28870967

9

pTis and pT1a Ipsilateral Breast Tumor Recurrence Is Associated with Good Prognosis after Salvage Surgery.

Ishitobi M, Fukui R, Hashimoto Y, Kittaka N, Nakayama T, Tamaki Y. Ishitobi M, et al. Among authors: nakayama t. Oncology. 2018;94(1):12-18. doi: 10.1159/000480516. Epub 2017 Oct 11. Oncology. 2018. PMID: 29017163

10

A prospective feasibility study applying the ACOSOG Z0011 criteria to Japanese patients with early breast cancer undergoing breast-conserving surgery.

Kittaka N, Tokui R, Ota C, Hashimoto Y, Motomura K, Ishitobi M, Nakayama T, Tamaki Y. Kittaka N, et al. Among authors: nakayama t. Int J Clin Oncol. 2018 Oct;23(5):860-866. doi: 10.1007/s10147-018-1297-0. Epub 2018 May 22. Int J Clin Oncol. 2018. PMID: 29789974

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

5,351 results

Search Page

Filters